UniQure Needs Longer-Term Data For Hemophilia B Gene Therapy EtranaDez

Company Presents HOPE-B Data At R&D Day

 
• By Alaric DeArment
Hemophilia_525478450_1200.jpg
uniQure presented an update to data from its Phase III HOPE-B study of etranacogene dezaparvovec in hemophilia B • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies